MECHANISMS OF ACUTE EOSINOPHIL MOBILIZATION FROM THE BONE-MARROW STIMULATED BY INTERLEUKIN-5 - THE ROLE OF SPECIFIC ADHESION MOLECULES AND PHOSPHATIDYLINOSITOL 3-KINASE
Rt. Palframan et al., MECHANISMS OF ACUTE EOSINOPHIL MOBILIZATION FROM THE BONE-MARROW STIMULATED BY INTERLEUKIN-5 - THE ROLE OF SPECIFIC ADHESION MOLECULES AND PHOSPHATIDYLINOSITOL 3-KINASE, The Journal of experimental medicine, 188(9), 1998, pp. 1621-1632
Mobilization of bone marrow eosinophils is a critical early step in th
eir trafficking to the lung during allergic inflammatory reactions. We
have shown previously that the cytokine interleukin (IL)-5, generated
during an allergic inflammatory reaction in the guinea pig, acts syst
emically to mobilize eosinophils from the bone marrow. Here, we have i
nvestigated the mechanisms underlying this release process. Examinatio
n by light and electron microscopy revealed the rapid migration of eos
inophils from the hematopoietic compartment and across the bone marrow
sinus endothelium in response to IL-5. Using an in situ perfusion sys
tem of the guinea pig hind limb, we showed that IL-5 stimulated a dose
-dependent selective release of eosinophils from the bone marrow. Eosi
nophils released from the bone marrow in response to IL-5 expressed in
creased levels of beta(2) integrin and a decrease in L-selectin, but n
o change in or, integrin levels. A beta(2) integrin-blocking antibody
markedly inhibited the mobilization of eosinophils from the bone marro
w stimulated by IL-5. In contrast, an alpha(4) integrin blocking antib
ody increased the rate of eosinophil mobilization induced by IL-5. In
vitro we demonstrated that IL-5 stimulates the selective chemokinesis
of bone marrow eosinophils, a process markedly inhibited by two struct
urally distinct inhibitors of phosphatidylinositol 3-kinase, wortmanni
n and LY294002. Wortmannin was also shown to block eosinophil release
induced by IL-5 in the perfused bone marrow system. The parallel obser
vations on the bone marrow eosinophil release process and responses in
isolated eosinophils in vitro suggest that eosinophil chemokinesis is
the driving force for release in vivo and that this release process i
s regulated by alpha(4) and beta(2), integrins acting in opposite dire
ctions.